What is the function of obeticholic acid? What liver diseases is it effective in treating?

Obeticholic acid (OCA) is a bile acid analogue mainly used to treat chronic hepatobiliary diseases. Its main mechanism of action is to activate the farnesol Currently, the drug is mainly used to treat primary biliary cholangitis (PBC) and has potential therapeutic value in the field of liver diseases such as non-alcoholic steatohepatitis (NASH).

Obeticholic acid has been approved for the treatment of primary biliary cholangitis (PBC), especially in patients who are intolerant or have an inadequate response to treatment with ursodeoxycholic acid (UDCA). PBC is a chronic autoimmune liver disease, mainly characterized by damage to small intrahepatic bile ducts and cholestasis, which may eventually lead to cirrhosis and liver failure. Obeticholic acid can reduce the accumulation of bile acids in the liver and reduce liver enzyme levels (such as alkaline phosphataseALP), thereby slowing down disease progression and improving patients' quality of life.

Research shows that obeticholic acid has potential in the treatment of non-alcoholic steatohepatitis (NASH). NASH is a liver disease caused by fat accumulation and chronic inflammation, which may progress to liver fibrosis or even cirrhosis. Obeticholic acid can reduce liver fat accumulation, reduce inflammatory response, and improve liver fibrosis by activating FXR receptors. However, the applicability of obeticholic acid in the treatment of NASH is still in the clinical research stage and has not yet been widely approved.

In addition toPBC and NASH, obeticholic acid is also being studied for the treatment of cholestatic liver disease, liver fibrosis, and primary sclerosing cholangitis (PSC). Since theFXR receptor plays an important role in hepatobiliary metabolism, obeticholic acid has broad potential in regulating bile acid metabolism, reducing liver damage, and improving inflammation. However, for these indications, obeticholic acid is still in clinical trials and may become a treatment option for more liver diseases in the future.

Reference materials:https://en.wikipedia.org/wiki/Obeticholic_acid